DrugPatentWatch Database Preview
Litigation Details for Senju Pharmaceutical Co. v. Lupin Limited (Fed. Cir. 2013)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Senju Pharmaceutical Co. v. Lupin Limited (Fed. Cir. 2013)
| Docket | Start Trial | Date Filed | 2013-09-10 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 4,551,456; 4,980,470; 6,333,045 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Senju Pharmaceutical Co. v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Senju Pharmaceutical Co. v. Lupin Limited (Fed. Cir. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-01-27 | 45 | The ‘456 patent U.S. Patent No. 4,551,456 (A2711-A2713) The ‘465 patent … U.S. Patent No. 4,780,465 (A2714-A2718) The ‘470 patent U.S. Patent No. 4,980,470 (A2719…the asserted ‘045 patent claims and the ‘456 patent is that the ‘456 patent does not specifically…and patent holder Senju Pharmaceutical Co., Ltd. The ‘045 patent … Patent and Reexamination Certificate (U.S. Patent No. 6,333, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
